
Monetary research
Indian pharmaceutical companies have started investing heavily in research, especially after India became TRIPs compliant. As the R&D budgets of various companies sky rocket, Nandini Patwardhan looks at the way ahead.
Monetary research
Indian pharmaceutical companies have started investing heavily in research, especially after India became TRIPs compliant. As the R&D budgets of various companies sky rocket, Nandini Patwardhan looks at the way ahead.